je.st
news
Tag: therapy
Rebuilding a Harley provides therapy to Akron man recovering from cancer
2015-10-20 02:58:51| Automakers - Topix.net
Ron Greer of Akron, a cancer survivor, with the "breast cancer awareness" Harley Davidson motorcycle that he built complete with pink tires at his home Tuesday, Oct. 13, 2015 in Akron, Ohio. Ron Greer of Akron, a cancer survivor, with the "breast cancer awareness" Harley Davidson motorcycle that he built complete with pink tires at his home in Akron.
Tags: man
cancer
therapy
harley
Eclipse(TM) Treatment Planning Software from Varian Now Offers Robust Optimization and Proton Therapy Dose Calculation Tools
2015-10-19 12:31:13| Industrial Newsroom - All News for Today
The latest software release, including the Acuros proton therapy algorithm for faster, more accurate dose calculation, receives FDA 510(k) clearance PALO ALTO, Calif. Varian Medical Systems (NYSE: VAR) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the latest release of the...
Tags: software
tools
offers
planning
Sponsor Content: Howl-O-Ween Hoof and Woof set to raise funds for West Michigan Therapy Dogs
2015-10-08 09:46:05| Grocery - Topix.net
It's quite the treat to be in the company of dogs. As our designated "best friends," finding better companionship is difficult.
Tags: content
set
west
sponsor
Results from Mercks Phase 3 Study of Investigational Chronic Hepatitis C Therapy Elbasvir/Grazoprevir in Patients with Advanced Chronic Kidney Disease Published in The Lancet
2015-10-06 01:01:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the publication of results from C-SURFER, the first Phase 31 clinical trial to investigate an all-oral, ribavirin-free chronic hepatitis C virus (HCV) treatment regimen in treatment-nave and treatment-experienced patients with advanced chronic kidney disease (CKD) stages 4 or 5 and chronic HCV genotype 1 (GT1) infection. Language: English Contact: MerckMedia Contacts:Doris Li, 908-246-5701Sarra Herzog, 201-669-6570orInvestor Contacts:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
09.04.15 -- Viamet And MSGERC Collaborate On Novel Therapy For Cryptococcal Meningitis
2015-09-03 02:41:51| drugdiscoveryonline News Articles
09/04/15 Drug Discovery Online Newsletter
Tags: therapy
collaborate
meningitis
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] next »